<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Psychiatry">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Psychiatry</JournalTitle>
      <Issn>1735-4587</Issn>
      <Volume>11</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2016</Year>
        <Month>10</Month>
        <Day>09</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Association between Neuregulin-1 Gene Variant &#x200E;&#x200E;(rs2439272) and Schizophrenia and its Negative &#x200E;Symptoms in an Iranian Population</title>
    <FirstPage>147</FirstPage>
    <LastPage>153</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Sadegh</FirstName>
        <LastName>Yoosefee</LastName>
        <affiliation locale="en_US">Neuroscience and Neurology Research Center, Qom University of Medical Sciences, Qom, &#x200E;Iran. AND Department of Neuroscience, School of Advanced Technologies in Medicine, Iran &#x200E;University of Medical Sciences &#x200E;&#x200E;(IUMS), Tehran, Iran&#x200E;. AND Health and Religion Research Center, Qom University of Medical Sciences, Qom, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Esmaeil</FirstName>
        <LastName>Shahsavand Ananloo</LastName>
        <affiliation locale="en_US">Department of Adult Psychiatry, Roozbeh Hospital, School of Medicine, Tehran University of &#x200E;Medical Sciences (TUMS), &#x200E;Tehran, Iran.&#x200E;AND Department of Genomic Psychiatry and Behavioral Genomics (DGPBG), Roozbeh &#x200E;Psychiatry Hospital, School of &#x200E;Medicine, Tehran University of Medical Sciences (TUMS), &#x200E;Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad-Taghi</FirstName>
        <LastName>Joghataei</LastName>
        <affiliation locale="en_US">Department of Neuroscience, School of Advanced Technologies in Medicine, Iran &#x200E;University of Medical Sciences &#x200E;&#x200E;(IUMS), Tehran, Iran&#x200E;.</affiliation>
      </Author>
      <Author>
        <FirstName>Morteza</FirstName>
        <LastName>Karimipour</LastName>
        <affiliation locale="en_US">Molecular Medicine Group, Pasteur Institute of Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mahmoudreza</FirstName>
        <LastName>Hadjighassem</LastName>
        <affiliation locale="en_US">Department of Neuroscience and addiction studies, School of Advanced Technologies in Medicine, Tehran &#x200E;University of Medical &#x200E;Sciences (TUMS), Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Hoorie</FirstName>
        <LastName>Mohaghghegh</LastName>
        <affiliation locale="en_US">Department of Neuroscience and addiction studies, School of Advanced Technologies in Medicine, Tehran &#x200E;University of &#xD;
Medical &#x200E;Sciences (TUMS), Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mehdi</FirstName>
        <LastName>Tehrani-Doost</LastName>
        <affiliation locale="en_US">Department of Child and Adolescent Psychiatry, Roozbeh Hospital, School of Medicine, &#x200E;Tehran University of Medical Sciences (TUMS), Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Amir-Abbas</FirstName>
        <LastName>Rahimi</LastName>
        <affiliation locale="en_US">Molecular Medicine Group, Pasteur Institute of Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Hamid</FirstName>
        <LastName>Mostafavi Abdolmaleky</LastName>
        <affiliation locale="en_US">Department of Genetics &amp; Genomics, Boston University School of Medicine, Boston, MA, &#x200E;United States.</affiliation>
      </Author>
      <Author>
        <FirstName>Maryam</FirstName>
        <LastName>Hatami</LastName>
        <affiliation locale="en_US">Department of Adult Psychiatry, Roozbeh Hospital, School of Medicine, Tehran University of &#x200E;Medical Sciences (TUMS), &#x200E;Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2016</Year>
        <Month>08</Month>
        <Day>23</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2016</Year>
        <Month>08</Month>
        <Day>23</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Objective: Although the etiology of schizophrenia is unknown, it has a significant genetic component. &#x200E;A number of studies have indicated that neuregulin-1 (NRG1) gene may play a role in the &#x200E;pathogenesis of schizophrenia. In this study, we examined whether the rs2439272 of NRG1 &#x200E;is associated with schizophrenia and its negative symptoms in an Iranian population.&#x200E;
Method: Rs2439272 was genotyped in 469 participants including 276 unrelated patients with schizophrenia and 193 healthy controls. The association of genetic risk with PANSS, and negative &#x200E;symptoms was examined in the total, male and female samples. COCAPHASE and &#x200E;CLUMP22 programs were used to compare the allele and genotype frequencies, and &#x200E;general linear regression was used to analyze the quantitative dependent variables by the &#x200E;selected variant.&#x200E;
Results: In this study, it was revealed that the G allele of rs2439272 might be an allele with the &#x200E;increased risk of developing schizophrenia, especially in the male participants. In addition, &#x200E;significant differences were found between the G allele and GG genotype frequencies and &#x200E;PANSS, and negative symptoms in the total and male participants.&#x200E;
Conclusion: Our results supported the association between rs2439272 in NRG1 gene and risk of &#x200E;schizophrenia and its negative symptoms in an Iranian population.</abstract>
    <web_url>https://ijps.tums.ac.ir/index.php/ijps/article/view/778</web_url>
    <pdf_url>https://ijps.tums.ac.ir/index.php/ijps/article/download/778/575</pdf_url>
  </Article>
</Articles>
